Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy
Autor(a) principal: | |
---|---|
Data de Publicação: | 1997 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S1516-31801997000400006 http://repositorio.unifesp.br/handle/11600/508 |
Resumo: | INTRODUCTION: An inhibitory serum factor of mixed lymphocyte culture (MLC) has been associated with successful pregnancy after lymphocyte transfusion in women with unexplained recurrent spontaneous abortions (RSA). OBJECTIVE: Investigate whether the inhibitory serum factor of MLC is essential for a successful pregnancy. METHOD: Sera from 33 healthy pregnant women and from 40 women with RSA were assessed by a one-way MLC in which the woman's lymphocytes were stimulated with her partner's lymphocytes or with third party lymphocytes. RESULTS: An inhibitory serum effect (inhibition > 50% as compared to normal serum) was detected in 45% of the pregnant women who had at least 1 previous parity, in 8% of the primigravidea, in 29% of those with one abortion and in 58% of those with more than one abortion. CONCLUSION: MLC inhibitory serum factor does not seem to be an essential factor for pregnancy development. Therefore, it should not be considered as a parameter for the assessment of RSA patients. |
id |
UFSP_0bf1af1078cdfa7b2264cc3ca275d9bc |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/508 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancyMixed lymphocyte culture testPregnancyHabitual abortionINTRODUCTION: An inhibitory serum factor of mixed lymphocyte culture (MLC) has been associated with successful pregnancy after lymphocyte transfusion in women with unexplained recurrent spontaneous abortions (RSA). OBJECTIVE: Investigate whether the inhibitory serum factor of MLC is essential for a successful pregnancy. METHOD: Sera from 33 healthy pregnant women and from 40 women with RSA were assessed by a one-way MLC in which the woman's lymphocytes were stimulated with her partner's lymphocytes or with third party lymphocytes. RESULTS: An inhibitory serum effect (inhibition > 50% as compared to normal serum) was detected in 45% of the pregnant women who had at least 1 previous parity, in 8% of the primigravidea, in 29% of those with one abortion and in 58% of those with more than one abortion. CONCLUSION: MLC inhibitory serum factor does not seem to be an essential factor for pregnancy development. Therefore, it should not be considered as a parameter for the assessment of RSA patients.INTRODUÇÃO: A presença de fator sérico inibidor de cultura mista de linfócitos (CML) tem sido associada ao sucesso gesticional observado em mulheres com história de abortameneto de repetição sem etiologia (AER-SED) submetidas a transfusão de linfócitos. OBJETIVO:Investigar se a presença de fator sérico inibidor de CML é essencial para o sucesso gestional. MÉTODO: Soros de 33 gestantes saudáveis e 40 mulheres com AER-SED foram avaliados em CML unidericional, em que os linfócitos das mulheres foram estimulados por linfócitos de seus parceiros ou de indivíduos não aparentados. RESULTADOS: Um efeito inibidor (inibição > 50% quanto comparado com soro normal) foi detectado em 45% das gestantes a partir da 2ªgestação 8% das primegestas, em 29% das abortadeiras primárias e, em 58% das secundárias. CONCLUSÃO: Este fator não parece ser elemento essencial para o sucesso gestional. Portanto, não deve ser considerado parâmetro para avaliação de pacientes com ARE-SED.Universidade Federal de São Paulo (UNIFESP) EPM Pediatrics DepartmentUNIFESP, EPM, Pediatrics DepartmentSciELOAssociação Paulista de Medicina - APMUniversidade Federal de São Paulo (UNIFESP)Daher, Silvia [UNIFESP]Fonseca, Flavia [UNIFESP]Mattar, Rosiane [UNIFESP]Musatti, Chloe Camba [UNIFESP]Gerbase-Lima, Maria [UNIFESP]2015-06-14T13:24:37Z2015-06-14T13:24:37Z1997-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1485-1489application/pdfhttp://dx.doi.org/10.1590/S1516-31801997000400006São Paulo Medical Journal. Associação Paulista de Medicina - APM, v. 115, n. 4, p. 1485-1489, 1997.10.1590/S1516-31801997000400006S1516-31801997000400006.pdf1516-3180S1516-31801997000400006http://repositorio.unifesp.br/handle/11600/508engSão Paulo Medical Journalinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-06T06:25:56Zoai:repositorio.unifesp.br/:11600/508Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-06T06:25:56Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy |
title |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy |
spellingShingle |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy Daher, Silvia [UNIFESP] Mixed lymphocyte culture test Pregnancy Habitual abortion |
title_short |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy |
title_full |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy |
title_fullStr |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy |
title_full_unstemmed |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy |
title_sort |
Inhibitory serum factor of lymphoproliferative response to allogeneic cells in pregnancy |
author |
Daher, Silvia [UNIFESP] |
author_facet |
Daher, Silvia [UNIFESP] Fonseca, Flavia [UNIFESP] Mattar, Rosiane [UNIFESP] Musatti, Chloe Camba [UNIFESP] Gerbase-Lima, Maria [UNIFESP] |
author_role |
author |
author2 |
Fonseca, Flavia [UNIFESP] Mattar, Rosiane [UNIFESP] Musatti, Chloe Camba [UNIFESP] Gerbase-Lima, Maria [UNIFESP] |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) |
dc.contributor.author.fl_str_mv |
Daher, Silvia [UNIFESP] Fonseca, Flavia [UNIFESP] Mattar, Rosiane [UNIFESP] Musatti, Chloe Camba [UNIFESP] Gerbase-Lima, Maria [UNIFESP] |
dc.subject.por.fl_str_mv |
Mixed lymphocyte culture test Pregnancy Habitual abortion |
topic |
Mixed lymphocyte culture test Pregnancy Habitual abortion |
description |
INTRODUCTION: An inhibitory serum factor of mixed lymphocyte culture (MLC) has been associated with successful pregnancy after lymphocyte transfusion in women with unexplained recurrent spontaneous abortions (RSA). OBJECTIVE: Investigate whether the inhibitory serum factor of MLC is essential for a successful pregnancy. METHOD: Sera from 33 healthy pregnant women and from 40 women with RSA were assessed by a one-way MLC in which the woman's lymphocytes were stimulated with her partner's lymphocytes or with third party lymphocytes. RESULTS: An inhibitory serum effect (inhibition > 50% as compared to normal serum) was detected in 45% of the pregnant women who had at least 1 previous parity, in 8% of the primigravidea, in 29% of those with one abortion and in 58% of those with more than one abortion. CONCLUSION: MLC inhibitory serum factor does not seem to be an essential factor for pregnancy development. Therefore, it should not be considered as a parameter for the assessment of RSA patients. |
publishDate |
1997 |
dc.date.none.fl_str_mv |
1997-08-01 2015-06-14T13:24:37Z 2015-06-14T13:24:37Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S1516-31801997000400006 São Paulo Medical Journal. Associação Paulista de Medicina - APM, v. 115, n. 4, p. 1485-1489, 1997. 10.1590/S1516-31801997000400006 S1516-31801997000400006.pdf 1516-3180 S1516-31801997000400006 http://repositorio.unifesp.br/handle/11600/508 |
url |
http://dx.doi.org/10.1590/S1516-31801997000400006 http://repositorio.unifesp.br/handle/11600/508 |
identifier_str_mv |
São Paulo Medical Journal. Associação Paulista de Medicina - APM, v. 115, n. 4, p. 1485-1489, 1997. 10.1590/S1516-31801997000400006 S1516-31801997000400006.pdf 1516-3180 S1516-31801997000400006 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
São Paulo Medical Journal |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
1485-1489 application/pdf |
dc.publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268340062912512 |